Raquel Billiones

Alexion (AstraZeneca Rare Disease)

Raquel Billiones has a PhD in Biology has been a regulatory writer for >17 years, covering both pharmaceuticals and medical devices. Her core competencies include clinical trials and submissions documents, data disclosure and protection, and project and people management. Over the years, she took on a wide range of industry positions, as freelancer, as employed regulatory writer, and as head of medical writing departments in the CRO and big pharma settings. Raquel is an active EMWA member since 2006, serving in various roles, including:
• Medical Writing editorial board member since 2010, currently Editor-in-Chief
• Education Committee member and workshop leader since 2020
• Co-founder of the SIGs on Medical Devices and on Sustainability
Her current industry role is Director of Medical Writing at Alexion (AstraZeneca Rare Disease), with designation as group SME for medical devices and delivery systems